Tuesday, 1 October 2024
  
Login

Australia's most trusted
source of pharma news

Tuesday, 01 October 2024
News

Pharmas move up the PBS queue

Posted 30 September 2024 AM

Roughly half of the 24 drugs recommended by the PBAC in July 2024 are officially on the road to government subsidy after their sponsors gave notice of intent, but some are moving quicker than others.

At the head of the que is a new formulation of Pfizer's chemotherapeutic Methoblastin. The genericised medication is the only drug recommended at the meeting that has reached the 'agreement to listing arrangements' stage.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (6)

Sales & Customer Relations (15)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (8)

Other (9)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.